236 related articles for article (PubMed ID: 15381464)
1. Treatment of relapses in aggressive non Hodgkin's lymphoma.
Bosly A
Bull Cancer; 2004; 91(7-8):E261-73. PubMed ID: 15381464
[TBL] [Abstract][Full Text] [Related]
2. Salvage therapy for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Bierman P; Armitage JO
Oncology (Williston Park); 1987 Nov; 1(9):11-21. PubMed ID: 3079492
[TBL] [Abstract][Full Text] [Related]
3. Treatment for non-Hodgkin's lymphoma in relapse. What are the alternatives?
Vose JM
N Engl J Med; 1995 Dec; 333(23):1565-6. PubMed ID: 7477176
[No Abstract] [Full Text] [Related]
4. High-dose therapy for aggressive non-Hodgkin's lymphoma.
Pettengell R
Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):521-4. PubMed ID: 8958405
[No Abstract] [Full Text] [Related]
5. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
7. Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens.
Ardeshna KM; Kakouros N; Qian W; Powell MG; Saini N; D'Sa S; Mackinnon S; Hoskin PJ; Goldstone AH; Linch DC
Br J Haematol; 2005 Aug; 130(3):363-72. PubMed ID: 16042685
[TBL] [Abstract][Full Text] [Related]
8. [Therapy intensification with autologous transplantation in non-Hodgkin's lymphomas].
Bosly A; Gisselbrecht C
Bull Cancer; 2001 Sep; 88(9):877-87. PubMed ID: 11604361
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation in relapsed non-Hodgkin's lymphoma.
Atkins CD
N Engl J Med; 1996 Apr; 334(15):990; author reply 991-2. PubMed ID: 8596607
[No Abstract] [Full Text] [Related]
10. [Role of massive chemotherapy and bone marrow graft in the treatment of non-Hodgkin's lymphoma].
Bouffet E; Favrot M; Biron P; Philip T
Bull Cancer; 1990; 77(2):159-67. PubMed ID: 2180504
[TBL] [Abstract][Full Text] [Related]
11. [Salvage treatments in non-Hodgkin's lymphoma. I].
Torello E; Koziner B
Sangre (Barc); 1993 Feb; 38(1):37-45. PubMed ID: 8470034
[No Abstract] [Full Text] [Related]
12. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Aydin S; Dührsen U; Nückel H
Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
[TBL] [Abstract][Full Text] [Related]
13. [Experience with non-Hodgkin's lymphoma].
Biron P; Droz JP
Bull Cancer; 1995; 82 Suppl 1():53s-55s. PubMed ID: 7626855
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
15. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
16. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
[TBL] [Abstract][Full Text] [Related]
17. [Current results of intensive chemotherapy as salvage with bone marrow graft in highly malignant T lymphomas. Apropos of 10 cases].
Meziane F; Philip T; Biron P; Bouffet E; Rebattu P; Colin C; Frappaz D; Souillet G; Philip I; Favrot M
Pediatrie; 1988; 43(7):637-44. PubMed ID: 3059315
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of aggressive non-Hodgkin's lymphomas].
López A; Palacio C
Med Clin (Barc); 1998 May; 110(16):614-8. PubMed ID: 9656199
[No Abstract] [Full Text] [Related]
19. Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Clavio M; Garrone A; Pierri I; Michelis GL; Balocco M; Albarello A; Varaldo R; Canepa P; Miglino M; Ballerini F; Canepa L; Gobbi M
Oncol Rep; 2005 Oct; 14(4):933-40. PubMed ID: 16142354
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in relapsed non-Hodgkin's lymphoma.
Koehne CH; Daniel P
N Engl J Med; 1996 Apr; 334(15):990-1; author reply 991-2. PubMed ID: 8596609
[No Abstract] [Full Text] [Related]
[Next] [New Search]